Page 147 - FINAL PROGRAMME 2017
P. 147
11:30 O-234 Gonadotropin endocytosis as a biomarker of optimal FSH dosage – a randomised clinical trial
A. Lobato-Pascual1, M. Raki2, G. Greggains1, P. Fedorcsak1
1Institute of Gynecology, Department of Reproductive Medicine, Oslo, Norway 2Laboratory Medicine, Department of Pathology, Oslo, Norway
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 147
SCIENTIFIC PROGRAMME WEDNESDAY, 5 JULY
